Therapeutic effect of ibrutinib, a selective Bruton’s tyrosine kinase inhibitor, in orbital fibroblasts from patients with Graves’ orbitopathy

• Hyun Young Park,

  Roles Writing – original draft

  Affiliations Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Republic of Korea, Siloam Eye Hospital, Seoul, Republic of Korea

  https://orcid.org/0000-0002-1673-6392

  ⨯
• Min Kyung Chae,

  Roles Visualization

  Affiliation Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Republic of Korea

  ⨯
• JaeSang Ko,

  Roles Writing – review & editing

  Affiliation Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Republic of Korea

  ⨯
• Don O. Kikkawa,

  Roles Writing – review & editing

  Affiliation Division of Oculofacial Plastic and Reconstructive Surgery, Department of Ophthalmology, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Sun Young Jang ,

  Contributed equally to this work with: Sun Young Jang, Jin Sook Yoon

  Roles Conceptualization, Supervision, Writing – review & editing

  Affiliation Department of Ophthalmology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea

  https://orcid.org/0000-0002-4723-3712

  ⨯
• Jin Sook Yoon

  Contributed equally to this work with: Sun Young Jang, Jin Sook Yoon

  Roles Conceptualization, Methodology, Supervision, Writing – review & editing

  * E-mail: yoonjs@yuhs.ac

  Affiliation Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Republic of Korea

  https://orcid.org/0000-0002-8751-9467

  ⨯